Merck
MRK
#40
Rank
A$510.86 B
Marketcap
A$207.07
Share price
-0.80%
Change (1 day)
61.06%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$5.51

According to Merck's latest financial reports the company's current EPS (TTM) is A$4.99. In 2025 the company made an earnings per share (EPS) of A$10.20 an increase over its 2024 EPS that were of A$9.43.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.51-45.96%
2025A$10.208.15%
2024A$9.434308.46%
2023A$0.21-97.32%
2022A$8.0010.92%
2021A$7.2184.68%
2020A$3.90-27.2%
2019A$5.3663.44%
2018A$3.28151.11%
2017A$1.31-54.58%
2016A$2.8830.21%
2015A$2.21-61.99%
2014A$5.81180.51%
2013A$2.07-31.82%
2012A$3.046.62%
2011A$2.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.19 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.80 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.83-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.04 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.40 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.21 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.57-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.97-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.42 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.91-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel